177 related articles for article (PubMed ID: 37185610)
21. Follicular lymphoma and marginal zone lymphoma: how many diseases?
Laurent C; Cook JR; Yoshino T; Quintanilla-Martinez L; Jaffe ES
Virchows Arch; 2023 Jan; 482(1):149-162. PubMed ID: 36394631
[TBL] [Abstract][Full Text] [Related]
22. Immunohistochemical analysis of the novel marginal zone B-cell marker IRTA1 in malignant lymphoma.
Ikeda JI; Kohara M; Tsuruta Y; Nojima S; Tahara S; Ohshima K; Kurashige M; Wada N; Morii E
Hum Pathol; 2017 Jan; 59():70-79. PubMed ID: 27666766
[TBL] [Abstract][Full Text] [Related]
23. Prognostic value of the Follicular Lymphoma International Prognostic Index score in marginal zone lymphoma: an analysis of clinical presentation and outcome in 144 patients.
Heilgeist A; McClanahan F; Ho AD; Witzens-Harig M
Cancer; 2013 Jan; 119(1):99-106. PubMed ID: 22736411
[TBL] [Abstract][Full Text] [Related]
24. Marginal zone B-cell lymphoma: A clinical comparison of nodal and mucosa-associated lymphoid tissue types. Non-Hodgkin's Lymphoma Classification Project.
Nathwani BN; Anderson JR; Armitage JO; Cavalli F; Diebold J; Drachenberg MR; Harris NL; MacLennan KA; Müller-Hermelink HK; Ullrich FA; Weisenburger DD
J Clin Oncol; 1999 Aug; 17(8):2486-92. PubMed ID: 10561313
[TBL] [Abstract][Full Text] [Related]
25. The clinical significance of increased large cells in marginal zone lymphoma.
Stueber T; Jaitly V; Moore EM
Hum Pathol; 2023 Nov; 141():130-138. PubMed ID: 37633532
[TBL] [Abstract][Full Text] [Related]
26. Multiple mucosa-associated lymphoid tissue organs involving marginal zone B cell lymphoma: organ-specific relationships and the prognostic factors. Consortium for improving survival of lymphoma study.
Oh SY; Kim WS; Kim JS; Kim SJ; Lee S; Lee DH; Won JH; Hwang IG; Kim MK; Lee SI; Chae YS; Yang DH; Kang HJ; Choi CW; Park J; Kim HJ; Kwon JH; Lee HS; Lee GW; Eom HS; Kwak JY; Lee WS; Suh C; Kim HJ
Int J Hematol; 2010 Oct; 92(3):510-7. PubMed ID: 20838958
[TBL] [Abstract][Full Text] [Related]
27. Primary spinal marginal zone lymphoma: case report and review of the literature.
Ahmadi SA; Frank S; Hänggi D; Eicker SO
Neurosurgery; 2012 Aug; 71(2):E495-508; discussion E508. PubMed ID: 22314752
[TBL] [Abstract][Full Text] [Related]
28. Epstein-Barr virus-associated large B-cell lymphoma transformation in marginal zone B-cell lymphoma: a series of four cases.
Camacho Castañeda FI; Dotor A; Manso R; Martín P; Prieto Pareja E; Palomo Esteban T; García Vela JA; Santonja C; Piris MA; Rodríguez Pinilla SM
Histopathology; 2020 Jul; 77(1):112-122. PubMed ID: 32145092
[TBL] [Abstract][Full Text] [Related]
29. Clonal relationship of marginal zone lymphoma and diffuse large B-cell lymphoma in Sjogren's syndrome patients: case series study and review of the literature.
Gorodetskiy VR; Probatova NA; Radenska-Lopovok SG; Ryzhikova NV; Sidorova YV; Sudarikov AB
Rheumatol Int; 2020 Mar; 40(3):499-506. PubMed ID: 31707561
[TBL] [Abstract][Full Text] [Related]
30. Marginal Zone Lymphoma: State-of-the-Art Treatment.
Sindel A; Al-Juhaishi T; Yazbeck V
Curr Treat Options Oncol; 2019 Dec; 20(12):90. PubMed ID: 31807935
[TBL] [Abstract][Full Text] [Related]
31. Cutaneous b-cell lymphomas of follicular and marginal zone types: use of Bcl-6, CD10, Bcl-2, and CD21 in differential diagnosis and classification.
de Leval L; Harris NL; Longtine J; Ferry JA; Duncan LM
Am J Surg Pathol; 2001 Jun; 25(6):732-41. PubMed ID: 11395550
[TBL] [Abstract][Full Text] [Related]
32. Current Treatments in Marginal Zone Lymphoma.
Alderuccio JP; Kahl BS
Oncology (Williston Park); 2022 Apr; 36(4):206-215. PubMed ID: 35436062
[TBL] [Abstract][Full Text] [Related]
33. Prevalence and Pattern of Autoimmune Conditions in Patients with Marginal Zone Lymphoma: A Single Institution Experience.
Dasanu CA; Bockorny B; Grabska J; Codreanu I
Conn Med; 2015 Apr; 79(4):197-200. PubMed ID: 26259295
[TBL] [Abstract][Full Text] [Related]
34. Immunophenotypic Characterization of Canine Splenic Follicular-Derived B-Cell Lymphoma.
Stein L; Bacmeister C; Ylaya K; Fetsch P; Wang Z; Hewitt SM; Kiupel M
Vet Pathol; 2019 May; 56(3):350-357. PubMed ID: 30636524
[TBL] [Abstract][Full Text] [Related]
35. Clinical Characteristics, Treatment and Evolution of Splenic and Nodal Marginal Zone Lymphomas-Retrospective and Multicentric Analysis of Portuguese Centers.
Rodrigues CD; Peixeiro RP; Viegas D; Chorão P; Couto ME; Gaspar CL; Fernandes JP; Alves D; Ribeiro LA; de Vasconcelos M P; Tomé AL; Badior M; Coelho H; Príncipe F; Chacim S; da Silva MG; Coutinho R
Clin Lymphoma Myeloma Leuk; 2021 Nov; 21(11):e839-e844. PubMed ID: 34326035
[TBL] [Abstract][Full Text] [Related]
36. Splenic and nodal marginal zone lymphomas are indolent disorders at high hepatitis C virus seroprevalence with distinct presenting features but similar morphologic and phenotypic profiles.
Arcaini L; Paulli M; Boveri E; Vallisa D; Bernuzzi P; Orlandi E; Incardona P; Brusamolino E; Passamonti F; Burcheri S; Schena C; Pascutto C; Cavanna L; Magrini U; Lazzarino M
Cancer; 2004 Jan; 100(1):107-15. PubMed ID: 14692030
[TBL] [Abstract][Full Text] [Related]
37. Transformed diffuse large B-cell lymphoma from marginal zone lymphoma in the anterior mediastinum: A case report and review of the literature.
Kitamura W; Asada N; Tabata T; Shibata R; Nishi T; Kato Y; Takasuka H; Fujiwara H; Ennishi D; Nishimori H; Fujii N; Matsuoka KI; Kiura K; Yoshino T; Maeda Y
J Clin Exp Hematop; 2022 Mar; 62(1):35-40. PubMed ID: 34840205
[TBL] [Abstract][Full Text] [Related]
38. Marginal zone lymphoma in elderly and geriatric patients.
Goede V
Best Pract Res Clin Haematol; 2017; 30(1-2):158-165. PubMed ID: 28288711
[TBL] [Abstract][Full Text] [Related]
39. Primary Breast Lymphoma in the United States: 1975-2013.
Thomas A; Link BK; Altekruse S; Romitti PA; Schroeder MC
J Natl Cancer Inst; 2017 Jun; 109(6):. PubMed ID: 28376147
[TBL] [Abstract][Full Text] [Related]
40. Risk Factors for Transformation to Higher-Grade Lymphoma and Its Impact on Survival in a Large Cohort of Patients With Marginal Zone Lymphoma From a Single Institution.
Alderuccio JP; Zhao W; Desai A; Gallastegui N; Ramdial J; Kimble E; de la Fuente MI; Rosenblatt JD; Chapman JR; Vega F; Reis IM; Lossos IS
J Clin Oncol; 2018 Oct; ():JCO1800138. PubMed ID: 30312133
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
